Barclays »

Travere Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.0M 664k 8.99
2023-09-30 $2.6M 289k 8.94
2023-06-30 $3.9M 253k 15.36
2023-03-31 $4.6M 203k 22.49
2022-12-31 $3.9M 185k 21.02
2022-09-30 $3.4M 137k 24.64
2022-06-30 $619k 26k 24.22
2022-03-31 $1.3M 49k 25.79